The more frequent injection site reactions with exenatide once weekly (22%) compared with semaglutide (1.2%) in SUSTAIN-3 could be a consequence of this ( The head-to-head studies within the SUSTAIN and PIONEER programs allow some comparison of the adverse effect profile ( Table 2 )
Like Saxenda and Ozempic, the 2.4 mg semaglutide will likely be quite expensive when released (
21, 2025, from Meleine, M
Kirtley, who has lost 181 pounds, says her outlook on life has improved
Weight loss results can vary, with some patients starting to see changes in a few weeks to a month when taking the appropriate dose
Risks are bruising, swelling, allergic reactions, and rare yet serious complications such as necrosis or filler displacement